Chinese Journal of Hepatology 2006 Issue 4 xiao xi

xiao xi

..............page:271,276,插7

Progress in silencing HBV gene expression by RNAi technologies
TANG Ni;HUANG Ai-long

..............page:318-320

Treatment of portal vein thrombus in liver transplantation
LI Bo

..............page:293-294

Relationship between abnormal expression of heat shock protein 90 and malignant transformation of hepatocytes
SU Xiao-qin;YAO Deng-fu

..............page:314-317

Primary malignant fibrous histiocytoma of the liver: an analysis of 3 cases
CHEN Qian;LI Qiang

..............page:313,317

Association of the CD28 gene promoter-372G/A polymorphism with chronic hepatitis B
CHEN Tao;CHEN Ming;WANG Li-ping;FENG Bo;LI Xiu-hua

..............page:312,320

The use of flow cytometry in detecting CMV-PP65 antigenemia for the diagnosis of CMV hepatitis
ZHAO Hong-can;XIANG Guo-qian;SHEN Hong-qiang

..............page:310-311

Stereotactic radiotherapy for hepatocellular carcinoma with portal tumor thrombi
REN Ben;SONG Jiang-bo;WANG Xiao-dong;SI Hong-xia;LIAO Yue-bin;ZHANG Fen-qin;ZHANG Zi-xia

..............page:308-309

Prevention of hepatic failure induced by BCG and lipopolysaccharide in mice using mycophenolate mofetil
YANG Yong-feng;TAN De-ming;XIE Yu-tao;ZHAO Wei;WEN Zhi-li

..............page:306-308

Lamivudine administration prevents fulminant hepatic failure in patients with severe chronic hepatitis B
CUI Jian-jun;ZHOU Bo-ping;DAI Wei

..............page:261-263

Monitoring portal vein complications following liver transplantation by color Doppler flow imaging
REN Xiu-yun;WANG Feng-shui;LIU Yu;CHEN Xin-guo;LI Wei;SHEN Zhong-yang;ZHUANG Hui

..............page:258-260

Liver transplantation for treating hepatocellular carcinoma
LIU Xiang-de;YANG Zhan-yu;WANG Shu-guang;BIE Ping;ZHENG Shu-guo;ZHANG Lei-da;HE Yu;LU Qian;YANG Zhi-qing;DONG Jia-hong

..............page:255-257

Experimental study on tolerance time limits from warm ischemia to cold preservation of liver grafts
ZHENG Shu-guo;FENG Xiao-bin;HE Zhen-ping;QING De-ke;LENG Jian-jun;DONG Jia-hong

..............page:250-254

Clinicopathological analysis of biliary tract complications on post-liver transplantation patients
WANG Zheng-lu;ZHANG Shu-ying;ZHU Cong-zhong;LI Hui;TANG Ying;SHEN Zhong-yang

..............page:247-249

Adult-to-adult living donor liver transplantation for decompensated end-stage liver diseases
LI Xiang-cheng;WANG Xue-hao;ZHANG Feng;XU San-rong;CHENG Feng;LI Guo-qiang;WANG Ke;QIAN Xiao-feng;MA Yue-feng

..............page:243-246

Improving the clinical results of liver transplantation in China
YAN Lü-nan

..............page:241-242

Effects of extracts of Rhizoma curcumae on angiotensin Ⅱ and its type 1 receptor expression in rat liver fibrosis induced by CCl4
YANG Ling;QIAN Wei;HOU Xiao-hua;XU Ke-shu;WANG Jian-ping

..............page:303-305

Screening differentially expressed genes of asymptomatic HBV carriers by suppression subtracted hybridization
TANG Cui-lan;CHEN Zhi;YANG Zheng-gang;ZHOU Lin-fu;CHEN Feng;PENG Guo-ping

..............page:302-303

A study of AFP and ALB expression in human mesenchymal stem cells induced by hepatopathy patient serum
ZHAO Wen-jing;CHEN Ya-jie;ZHAO Zhen-guo;LIU Wei;LIU Shu-rong;SUN Qing-guo;CHEN Xi

..............page:300-301

The value of CA19-9 in diagnosing hepatocellular carcinoma and intrahepatic cholangiocarcinoma
CHEN Yi;WANG Zhi-ming;REN Zheng-gang;LE Fan;ZHANG Bo-heng;XIA Jing-lin;YE Sheng-long;TANG Zhao-you

..............page:299-300

Expression of heparanase and b-FGF in HCC and their relationships with microvascular density
WANG Shun-xiang;TIAN Zhi-hong;WU Xiao-hui;ZHOU Shao-ying;PENG Li

..............page:297-298

Transarterial administration of GRGDSP combined with chemoembolization for treating hepatic carcinoma in rats
YIN Jun;LIANG Hui-min;QIAN Jun;XIA Feng;WANG Yong;DENG Xian-bo;WANG Wei;NI Lan;FENG Gan-sheng

..............page:295-296

Liver transplantation for end-stage alcoholic liver diseases
ZHOU Li-xin;YAN Lü-nan;ZENG Yong

..............page:288,292

Chemosensitization of hepatocellular carcinoma using antisense oligonucleotides
WANG Zhi-yan;LIN Ru-xian;WANG Sheng-qi

..............page:242,246

Prophylaxis of HBV reinfection by immune therapy after liver transplantation
LIU Zuo-jin;LI Sheng-wei

..............page:294-295

A clinical analysis of liver disease patients with abnormal glucose metabolism
ZHANG Xia;SHEN Wei;SHEN Ding-ming

..............page:289-292

Effect of hydroxycamptothecin on apoptosis-inducing factor (AIF) expression and on AIF translocation in human hepatocellular cancer cell SMMC-7721
FU Yu-rong;QIU Zong-yin;YAN Yu-rong

..............page:285-288

Expression and significance of hypoxia inducible factor-1 alpha in hepatocellular carcinoma tissues
ZHANG Fang-jie;TANG Wang-xian;WU Cui-huan;YAN Wei;GU Hua

..............page:281-284

Reconstructing the JAK/STATs signal pathway restored the anti-proliferative response of MHCC97 on interferon alpha
WU Wei-zhong;SUN Hui-chuan;GAO Yan-qin;WANG Lu;TANG Zhao-you;LIU Kang-da

..............page:277-280

A preliminary study on anti-liver cancer immunity of the virus-like particulate peptide-nucleic acid vaccine
GUO Hong;HAO Jia;WU Chao;FANG Dian-chun

..............page:272-276

Construction and expression of EGFP controlled HBV promoters in eukaryotic cells
XIE Na;WANG Xiao-yan;ZHANG Qiong;LIN Yuan-yuan;LIN Ju-sheng

..............page:268-271

The role of peripheral blood mononuclear cells (PBMC) of HBV-infected mothers in the intrauterine infection of their fetuses
LI Shu-hong;YUE Ya-fei;ZHANG Shu-lin;SHI Zi-yun;GUI Qiao-di

..............page:264-267